Strategy, Growth & Investment Committee
Guiding Sustainable Expansion and Innovation at Scale
Home ❯ Board Committee ❯ SGI
The Strategy, Growth and Investment Committee of DhiShi Scientific Private Limited provides strategic direction for organizational expansion, business development, partnerships, and long-term value creation across the DhiShi ecosystem.
As DhiShi operates across education (Pharmmax), research and publications (ScienceBy, Scilens Journals), diagnostics and laboratory services (FrontLabs), and medical communication (Medxury), this committee ensures that growth is structured, sustainable, and aligned with the company’s mission and governance standards.
Committee Vision
To build a future-ready organization that scales innovation responsibly, expands global collaborations, and creates long-term impact in healthcare, research, and education.
What We Do
The committee provides strategic oversight and advisory support in:
Long-term business planning and growth roadmaps
Market expansion and geographic scaling strategies
Strategic partnerships and institutional alliances
Investment evaluation and capital utilization
New vertical and product feasibility assessments
Innovation commercialization pathways
Roles & Responsibilities
The Strategy, Growth & Investment Committee is responsible for:
Advising the Board on growth strategies and diversification
Evaluating new business models and expansion opportunities
Reviewing major investments and funding utilization
Supporting partnerships with institutions, hospitals, and industry
Monitoring performance trends across business units
Guiding innovation-to-market translation strategies
Ensuring growth aligns with governance and ethics frameworks
Expertise & Experience Represented
The committee includes professionals with experience in:
Business strategy and corporate development
Healthcare and life sciences industry leadership
Entrepreneurship and startup ecosystems
Investment, venture advisory, and financial planning
Market entry and international expansion
Product development and commercialization
This blend ensures that decisions are strategic, realistic, and impact-oriented.
Responsible Growth Philosophy
The committee promotes:
Mission-aligned expansion over rapid scaling
Ethical partnerships and transparent investments
Long-term capacity building in institutions and regions
Innovation driven by healthcare needs, not trends alone
Growth is viewed not just as revenue, but as responsibility to communities, students, and patients.
Collaboration with Other Committees
The Strategy Committee works closely with:
Audit & Compliance Committee for financial governance
Research & Ethics Committee for innovation validation
Education Committee for academic market alignment
HR & Culture Committee for leadership and workforce scaling
CSR Committee for socially responsible expansion models
This ensures that strategic decisions are holistic and institution-centric.
Note on Global Strategic Participation
To strengthen global outlook and cross-border opportunities, DhiShi engages international business leaders, healthcare entrepreneurs, and innovation advisors who contribute strategic insights and market perspectives.
Call for Global Leaders
Be a Guardian of Trust at DhiShi
This is a call to those who believe that strong governance is the backbone of sustainable innovation.